IKCEST

Eksperimental'naia i klinicheskaia farmakologiia | Vol.67, Issue.6 | | Pages 3-7

[New directions in GABAergic pharmacology of anxiety and depression].

A V, Kaluev D D, Nutt

Abstract

New prospects in the use of drugs affecting central GABAergic system for the treatment of anxiety and depressive states are critically assessed. Both clinical (human) and experimental (animal) data on the mutual influence of various GABA-receptor modulators as well as the interaction of GABAergic system with neurohumoral mechanisms of stress are considered. Based on this analysis, new strategies in the GABAergic pharmacotherapy of anxiety and depression spectrum disorders are outlined.

Original Text (This is the original text for your reference.)

[New directions in GABAergic pharmacology of anxiety and depression].

+More

Keywords

gabaergic system anxiety and depressive states gabareceptor modulators gabaergic pharmacotherapy of anxiety and depression spectrum disorders neurohumoral mechanisms of stress

Cite this article

APA

MLA

Chicago

A V, Kaluev D D, Nutt,.[New directions in GABAergic pharmacology of anxiety and depression].. 67 (6),3-7.

Disclaimer: The translated content is provided by third-party translation service providers, and IKCEST shall not assume any responsibility for the accuracy and legality of the content.